Transgenic mouse models of AD are produced by over expressing mutant human APP alone or combined with transgenic presenilin 1 (PS1) and presenilin2 (PS2) genes in mice, which leads to Aβ plaque formation [24]. Here, PSEN1 is linked to Alzheimer disease.